Atopaxar Hydrobromide
Atopaxar, a reversible PAR-1 thrombin receptor antagonist, interferes with platelet signaling. Atopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome.
| Catalog Number | T1986L |
| Research Area | GPCR/G Protein |
| Molecular Formula | C29H39BrFN3O5 |
| CAS# | 474550-69-1 |
| Purity | 100.00% |
| SMILES | c1(c(c(cc2c1C(=N)N(C2)CC(=O)c1cc(c(c(c1)N1CCOCC1)OC)C(C)(C)C)OCC)OCC)F.Br |
| Size | 10 mg |
| Supplier Page | https://www.targetmol.com/compound/Atopaxar Hydrobromide |
| Additional Information | https://www.targetmol.com/datasheet/T1986L |
